Anti-SWAP1/ SWSAP1/ C19orf39 functional antibody

Anti-SWAP1/ SWSAP1/ C19orf39 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SWSAP1/SWSAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1606-Ab-1/ GM-Tg-hg-SE1606-Ab-2Anti-Human SWSAP1 monoclonal antibodyHuman
GM-Tg-rg-SE1606-Ab-1/ GM-Tg-rg-SE1606-Ab-2Anti-Rat SWSAP1 monoclonal antibodyRat
GM-Tg-mg-SE1606-Ab-1/ GM-Tg-mg-SE1606-Ab-2Anti-Mouse SWSAP1 monoclonal antibodyMouse
GM-Tg-cynog-SE1606-Ab-1/ GM-Tg-cynog-SE1606-Ab-2Anti-Cynomolgus/ Rhesus macaque SWSAP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1606-Ab-1/ GM-Tg-felg-SE1606-Ab-2Anti-Feline SWSAP1 monoclonal antibodyFeline
GM-Tg-cang-SE1606-Ab-1/ GM-Tg-cang-SE1606-Ab-2Anti-Canine SWSAP1 monoclonal antibodyCanine
GM-Tg-bovg-SE1606-Ab-1/ GM-Tg-bovg-SE1606-Ab-2Anti-Bovine SWSAP1 monoclonal antibodyBovine
GM-Tg-equg-SE1606-Ab-1/ GM-Tg-equg-SE1606-Ab-2Anti-Equine SWSAP1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1606-Ab-1/ GM-Tg-hg-SE1606-Ab-2; GM-Tg-rg-SE1606-Ab-1/ GM-Tg-rg-SE1606-Ab-2;
GM-Tg-mg-SE1606-Ab-1/ GM-Tg-mg-SE1606-Ab-2; GM-Tg-cynog-SE1606-Ab-1/ GM-Tg-cynog-SE1606-Ab-2;
GM-Tg-felg-SE1606-Ab-1/ GM-Tg-felg-SE1606-Ab-2; GM-Tg-cang-SE1606-Ab-1/ GM-Tg-cang-SE1606-Ab-2;
GM-Tg-bovg-SE1606-Ab-1/ GM-Tg-bovg-SE1606-Ab-2; GM-Tg-equg-SE1606-Ab-1/ GM-Tg-equg-SE1606-Ab-2
Products NameAnti-SWSAP1 monoclonal antibody
Formatmab
Target NameSWSAP1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SWSAP1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1606-Ag-1Recombinant multi-species SWAP1/ SWSAP1/ C19orf39 protein


    Target information

    Target IDGM-SE1606
    Target NameSWSAP1
    Gene ID126074,66962,363029,716529,611130,101098694,507152,100147390
    Gene Symbol and Synonyms2310047B19Rik,C19orf39,C20H19orf39,C7H19orf39,RGD1308026,SWS1AP1,SWSAP1,ZSWIM7AP1
    Uniprot AccessionQ6NVH7
    Uniprot Entry NameSWAP1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173928
    Target ClassificationN/A

    The target: SWSAP1, gene name: SWSAP1, also named as C19orf39, SWS1AP1, ZSWIM7AP1. Enables single-stranded DNA binding activity. Involved in double-strand break repair via homologous recombination and protein stabilization. Part of Shu complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.